Therefore, it is unclear whether anti-PD-L1 antibody has the same therapeutic effect as malignant melanoma and non-small cell lung cancer, because there may be an immune escape mechanism unique to thyroid cancer. The gene discussed is CD274; the disease is non-small cell lung carcinoma.